Being select­ed as one of the final­ist for the Achema Grün­der­preis, mk2 Biotech­nolo­gies attend­ed this year’s Achema World Forum in Frank­furt and pre­sent­ed at a booth and in an oral pre­sen­ta­tion the advan­tages of its supe­ri­or pep­tide syn­the­sis tech­nol­o­gy. In sev­er­al dis­cus­sions with experts and enthu­si­asts mk2 Biotech­nolo­gies under­lined its capa­bil­i­ties of scal­ably pro­duc­ing high puri­ty and authen­tic pep­tides with arbi­trary sequences.